UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017234
Receipt number R000019984
Scientific Title Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5-aminolevulinic acid on malignant skin tumors during Mohs surgery
Date of disclosure of the study information 2015/04/22
Last modified on 2015/04/22 14:34:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5-aminolevulinic acid on malignant skin tumors during Mohs surgery

Acronym

Intraoperative use of 5-aminolevulinic acid on malignant skin tumors during Mohs surgery

Scientific Title

Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5-aminolevulinic acid on malignant skin tumors during Mohs surgery

Scientific Title:Acronym

Intraoperative use of 5-aminolevulinic acid on malignant skin tumors during Mohs surgery

Region

Japan


Condition

Condition

basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)

Classification by specialty

Dermatology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This aimed to conduct a preliminary examination on the accuracy of intraoperative use of photodynamic diagnosis by spectroscopic detection from oral 5-aminolevulinic acid (5-ALA to identify tumor fluorescence from the peritumoral surgical pieces of tissue.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

a resection method using 5-ALA-mediated PDD as a treatment to completely remove malignant skin tumors

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of 5-aminolevulinic acid

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

the patients with malignant skin tumors

Key exclusion criteria

the patient with porphilia

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoru Aoyagi

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Dermatology

Zip code


Address

N15 W7, Kita-ku, Sapporo 060-8638, Japan

TEL

011-706-7387

Email

s.aoyagi@aoyagi-derm.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoru Aoyagi

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Dermatology

Zip code


Address

N15 W7, Kita-ku, Sapporo 060-8638, Japan

TEL

011-706-7387

Homepage URL


Email

s.aoyagi@aoyagi-derm.jp


Sponsor or person

Institute

Hokkaido University Graduate School of Medicine Department of Dermatology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 22 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 20 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 20 Day

Last follow-up date

2012 Year 05 Month 31 Day

Date of closure to data entry

2015 Year 04 Month 24 Day

Date trial data considered complete

2015 Year 04 Month 24 Day

Date analysis concluded

2015 Year 04 Month 24 Day


Other

Other related information



Management information

Registered date

2015 Year 04 Month 22 Day

Last modified on

2015 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019984


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name